These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 22067520

  • 1. Levosimendan in two neonates with ischemic heart failure and pulmonary hypertension.
    De Carolis MP, Piastra M, Bersani I, Pardeo M, Stival E, Tempera A, Romagnoli C, Conti G, De Rosa G.
    Neonatology; 2012; 101(3):201-5. PubMed ID: 22067520
    [Abstract] [Full Text] [Related]

  • 2. Levosimendan and pulmonary hypertension.
    Cavusoglu Y, Beyaztas A, Birdane A, Ata N.
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):478-80. PubMed ID: 20516805
    [No Abstract] [Full Text] [Related]

  • 3. Inotropic support in the NICU: ever more compounds in search of guidance? Commentary on J. Esch et al.: differential hemodynamic effects of levosimendan in a porcine model of neonatal hypoxia-reoxygenation (Neonatology 2012;101:192–200) and M.P. De Carolis et al.: levosimendan in two neonates with ischemic heart failure and pulmonary hypertension (Neonatology 2012;101:201–205).
    Thewissen L, Allegaert K.
    Neonatology; 2012 Jul; 101(3):206-9. PubMed ID: 22067565
    [No Abstract] [Full Text] [Related]

  • 4. Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
    Nieminen MS, Sandell EP.
    Ital Heart J; 2003 May; 4 Suppl 2():39S-44S. PubMed ID: 14635369
    [Abstract] [Full Text] [Related]

  • 5. The utility of levosimendan in the treatment of heart failure.
    Lehtonen L, Põder P.
    Ann Med; 2007 May; 39(1):2-17. PubMed ID: 17364447
    [Abstract] [Full Text] [Related]

  • 6. Effect of levosimendan on E/E' ratio in patients with ischemic heart failure.
    Duygu H, Ozerkan F, Nalbantgil S, Zoghi M, Akilli A, Akin M, Nazli C, Ergene O.
    Int J Cardiol; 2008 Jan 11; 123(2):201-3. PubMed ID: 17316845
    [Abstract] [Full Text] [Related]

  • 7. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C, Tousoulis D, Koumallos N, Marinou K, Stefanadis C.
    Pharmacol Ther; 2007 May 11; 114(2):184-97. PubMed ID: 17363065
    [Abstract] [Full Text] [Related]

  • 8. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure.
    Kerbaul F, Rondelet B, Demester JP, Fesler P, Huez S, Naeije R, Brimioulle S.
    Crit Care Med; 2006 Nov 11; 34(11):2814-9. PubMed ID: 16971854
    [Abstract] [Full Text] [Related]

  • 9. A promising new inotrope: levosimendan.
    Fotbolcu H, Duman D.
    Anadolu Kardiyol Derg; 2010 Apr 11; 10(2):176-82. PubMed ID: 20382619
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
    Earl GL, Fitzpatrick JT.
    Ann Pharmacother; 2005 Nov 11; 39(11):1888-96. PubMed ID: 16219899
    [Abstract] [Full Text] [Related]

  • 12. Levosimendan in heart failure after surgical repair of cardiac rupture.
    Torrado H, Ventura JL, Ruiz-Majoral A, Farrero E, Rodriguez-Castro D, Carrio ML, Miralles A.
    Minerva Cardioangiol; 2009 Feb 11; 57(1):137-8. PubMed ID: 19202525
    [No Abstract] [Full Text] [Related]

  • 13. Management of acute cardiac failure by intracoronary administration of levosimendan.
    Caimmi PP, Kapetanakis EI, Beggino C, Molinari C, Giustini G, Crosio E, Reposo G, Micalizzi E, Vacca G, Grossini E.
    J Cardiovasc Pharmacol; 2011 Sep 11; 58(3):246-53. PubMed ID: 21654504
    [Abstract] [Full Text] [Related]

  • 14. Evidence-based use of levosimendan in different clinical settings.
    De Luca L, Colucci WS, Nieminen MS, Massie BM, Gheorghiade M.
    Eur Heart J; 2006 Aug 11; 27(16):1908-20. PubMed ID: 16682381
    [Abstract] [Full Text] [Related]

  • 15. Levosimendan: a new approach for the treatment of patients with severe heart failure. A brief summary based on a clinical case.
    Morais J, Dias B, Pontes N.
    Rev Port Cardiol; 2003 Aug 11; 22(7-8):941-8. PubMed ID: 14587161
    [Abstract] [Full Text] [Related]

  • 16. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F.
    Ital Heart J; 2003 May 11; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [Abstract] [Full Text] [Related]

  • 17. [Acute hemodynamic and clinical effects of a new inotropic agent, levosimendan, in patients with severe heart failure].
    Porcu M, Orrù P.
    Ital Heart J Suppl; 2001 Feb 11; 2(2):205-6. PubMed ID: 11255888
    [No Abstract] [Full Text] [Related]

  • 18. New positive inotropic agents in the treatment of left ventricular dysfunction.
    De Luca L, Proietti P, Palombaro GL, Battagliese A, Celotto A, Bucciarelli Ducci C, Fedele F.
    Ital Heart J; 2004 Jun 11; 5 Suppl 6():63S-67S. PubMed ID: 15185917
    [Abstract] [Full Text] [Related]

  • 19. [Levosimendan in heart failure].
    Scelsi L, Campana C, Ghio S, Monti L, Opasich C, De Feo S, Cobelli F, Orlandi M, Di Pasquale G, Tavazzi L.
    Recenti Prog Med; 2004 Jun 11; 95(7-8):376-83. PubMed ID: 15303549
    [Abstract] [Full Text] [Related]

  • 20. Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording.
    Despas F, Trouillet C, Franchitto N, Labrunee M, Galinier M, Senard JM, Pathak A.
    Acute Card Care; 2010 Mar 11; 12(1):25-30. PubMed ID: 19929264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.